Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Second interim dividend

27 Jun 2025 17:57

RNS Number : 8462O
Experian plc
27 June 2025
 

Experian plc

 

 

Second interim dividend - exchange rate and Irish dividend withholding tax

 

 

27 June 2025 - Experian plc, the global data and technology company, hereby notifies the market that, further to the announcement on 14 May 2025 of a second interim dividend of 43.25 US cents per ordinary share payable on 18 July 2025 to shareholders on the register of members at the close of business on 20 June 2025, the exchange rate to be used to convert the dividend payment from US dollars to sterling pounds, for those shareholders who did not elect by 20 June 2025 to receive payment in US dollars, will be £1 = $1.37168. Accordingly, the sterling amount of dividend payable on 18 July 2025 to such shareholders will be approximately 31.5306 pence per share.

 

Shareholders who did not elect to receive UK sourced dividends through the income access share arrangements are reminded that, as previously advised, their dividends will be subject to Irish dividend withholding tax unless the Company's Registrars are in possession of a valid exemption form. As previously advised, the final date for submission of elections to receive UK sourced dividends via the income access share arrangements was 20 June 2025. In the absence of any such elections, previous elections or deemed elections will remain in force.

 

Contact:

 

Experian

Claire Murphy

Deputy Company Secretary

+353 (0) 87 421 3311

 

 

About Experian

 

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

 

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 23,300 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

 

Neither the content of the Company's website, nor the content of any website accessible from hyperlinks on the Company's website (or any other website), is incorporated into, or forms part of, this announcement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVQDLFLEQLEBBQ
Date   Source Headline
19th Jul 202312:22 pmRNSResult of AGM
13th Jul 20237:00 amRNSTrading update, first quarter
12th Jul 20239:30 amRNSHolding(s) in Company
11th Jul 20234:00 pmRNSHolding(s) in Company
6th Jul 20233:00 pmRNSHolding(s) in Company
30th Jun 20235:32 pmRNSSecond Interim Dividend
30th Jun 202310:30 amRNSTotal Voting Rights
28th Jun 202310:00 amRNSAdditional Listing
23rd Jun 202310:00 amRNSDirector/PDMR Shareholding
22nd Jun 202310:55 amRNSDirector/PDMR Shareholding
21st Jun 202311:00 amRNSAdditional Listing
14th Jun 202312:00 pmRNSAdditional Listing
14th Jun 202310:00 amRNSDirector/PDMR Shareholding
9th Jun 20234:00 pmRNSAnnual Financial Report
7th Jun 20233:49 pmRNSDirector/PDMR Shareholding
2nd Jun 20239:00 amRNSElections for second interim dividend
31st May 20231:12 pmRNSTotal Voting Rights
31st May 20239:32 amRNSAdditional Listing
22nd May 202312:46 pmRNSDirector/PDMR Shareholding
18th May 20232:29 pmRNSDirector/PDMR Shareholding
18th May 202310:20 amRNSDirector/PDMR Shareholding
17th May 20234:00 pmRNSDirector/PDMR Shareholding
17th May 202311:00 amRNSShare repurchases
17th May 20237:00 amRNSFull-year financial report
28th Apr 202310:15 amRNSTotal Voting Rights
12th Apr 20239:30 amRNSAdditional Listing
4th Apr 20239:45 amRNSAdditional Listing
31st Mar 202311:35 amRNSTotal Voting Rights
29th Mar 20239:20 amRNSAdditional Listing
28th Mar 20237:00 amRNSDirectorate Change
22nd Mar 20235:19 pmRNSTransaction in Own Shares
22nd Mar 20239:15 amRNSAdditional Listing
20th Mar 20235:18 pmRNSTransaction in Own Shares
17th Mar 20235:31 pmRNSTransaction in Own Shares
16th Mar 20235:09 pmRNSTransaction in Own Shares
16th Mar 20239:15 amRNSBlock listing Interim Review
15th Mar 20235:14 pmRNSTransaction in Own Shares
15th Mar 20239:15 amRNSAdditional Listing
14th Mar 20235:21 pmRNSTransaction in Own Shares
13th Mar 20235:31 pmRNSTransaction in Own Shares
10th Mar 20236:10 pmRNSTransaction in Own Shares
9th Mar 20235:22 pmRNSTransaction in Own Shares
8th Mar 20235:21 pmRNSTransaction in Own Shares
8th Mar 20239:15 amRNSAdditional Listing
7th Mar 20235:26 pmRNSTransaction in Own Shares
1st Mar 202312:00 pmRNSDirector/PDMR Shareholding
1st Mar 20239:15 amRNSAdditional Listing
28th Feb 202312:20 pmRNSTotal Voting Rights
22nd Feb 202310:00 amRNSAdditional Listing
15th Feb 202310:45 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.